Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel rabies virus vectors presented by U.S. Department of HHS

Sep. 4, 2012

Novel cathepsin D inhibitors patented by Merck KGaA

Sep. 4, 2012

Novartis prepares novel c-Met inhibitors

Sep. 4, 2012

New antimalarial agents presented by CSIR

Sep. 4, 2012

Wista Laboratories presents new tau aggregation inhibitors

Sep. 4, 2012

Astellas Pharma discloses new 5-HT5A receptor ligands

Sep. 3, 2012

Amgen presents novel beta-secretase inhibitors

Sep. 3, 2012

Novel bacterial efflux pump inhibitors patented by Rempex Pharmaceuticals

Sep. 3, 2012

Takeda presents novel inhibitors of ACC2

Sep. 3, 2012

Washington University presents new PET/SPECT imaging agents

Sep. 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...